Work

US FDA's Strategic Transition of Animal to Non‐Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize Innovation

Year: 2025

Type: article

Source: The Journal of Clinical Pharmacology

DOI: 10.1002/jcph.70127

Author: Rajesh Krishna

Institution: Certara (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

Open Access status: bronze

OpenAlex ID: W4416101671

FWCI: 1.09

Cites: 6

Cited by: 2

Related to: